Should the breast screening age be lowered? While the question has again been put forward, Australian experts remain unconvinced, saying participation among target groups is more important.
Is general practice ready for the genetic carrier screening surge? GPs must be educated and resourced to meet the ‘inevitable widespread uptake’ of the newly Medicare-funded service, says a new study.
Self-collection reaching under-screened populations Uptake of the cervical cancer screening option has been particularly high among Aboriginal and Torres Strait Islander people in the NT.
Lung cancer added to national screening register Eligible Australians could soon be offered a scan every two years in a bid to bolster early detection, but the RACGP says the register needs updating.
How can Australia increase BreastScreen participation? With more than one in two eligible women not taking part in the preventive screening program, the RACGP has suggested ways to boost engagement.
Pharmacy diabetes trial creating ‘serious concerns’ The RACGP has slammed a plan to screen for the disease in pharmacies, saying it could fragment care and put vulnerable patients at risk.
Feminist language being hijacked to market medical tests Narratives around empowerment and women’s rights are being co-opted to market interventions not backed by evidence, according to new research.
‘Breakthrough’ test for early dementia diagnosis a step closer Use of the blood test is expanding and local experts are excited about the impact it could have in Australia – should it become available.
Ban use of genetic testing for life insurance: RACGP While the college notes its potential to improve health outcomes, it suggests people could avoid testing if they risk cover being denied.
Real-world evidence demonstrates efficacy of HPV vaccine Zero cases of cervical cancer have been detected in Scotland among those who received the bivalent vaccine by age 12.